Review your content's performance and reach.
Become your target audience’s go-to resource for today’s hottest topics.
Understand your clients’ strategies and the most pressing issues they are facing.
Keep a step ahead of your key competitors and benchmark against them.
Articles: 1-10 of 155
USA - March 8 2024 Federal and state agencies are actively proposing and enacting health technology-related legislation and regulations. Trending…
USA - January 18 2024 We have been tracking the Corporate Transparency Act (CTA) since its passage by Congress on Jan. 1, 2021, as part of the National Defense…
USA - January 16 2024 Last month the United States Food and Drug Administration (“FDA”) issued its final guidance (“Guidance”) for the industry on cosmetic product…
USA - January 9 2024 On Jan. 5, the FDA authorized Florida’s Section 804 Implementation program (SIP), making Florida the first state to secure such approval.
USA - November 3 2023 On Oct. 23, the FDA issued draft guidance titled “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved…
USA - October 23 2023 FDA’s Commitment to Regulate Digital Health Technologies: The U.S. Food and Drug Administration (FDA) is establishing a Digital Health…
USA - August 22 2023 Concerns have grown tremendously in recent years regarding noncompliance in clinical trial reporting. Shockingly, the National Institutes of Health…
USA - August 15 2023 On August 7, 2023, the U.S. Food and Drug Administration (FDA, the Agency) published draft guidance aimed at assisting cosmetics companies with…
USA - June 28 2023 On June 27, 2023 the FDA published Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for…
USA - May 15 2023 On May 10, the U.S. Food and Drug Administration (FDA) published a discussion paper, “Using Artificial Intelligence & Machine Learning in the…